Diffusion Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy DFFN

*Your capital is at risk

$5.87

+0 (+0%)

At Close: Nov 28, 2023

Currently predicting for Thu, 6 Aug 2026

DFFN Live board

Community Bull/Bear

Target Next close

Join the DFFN prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

DFFN Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For DFFN

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

DFFN Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT DIFFUSION PHARMACEUTICALS INC

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
N NXDR $2.27	7.93%	Aug 03
MC $67.08	3.53%	Jul 31
FCX $62.63	10.79%	Jul 31
ARW $212.85	6.58%	Jul 30
BIIB $202.19	2.20%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by